Upcoming IPOs, Listings & Allotments (Dec 15–19): ICICI Prudential AMC, Corona Remedies, Wakefit & More in Spotlight

The Indian primary market heats up in the second half of December with major IPOs like ICICI Prudential AMC, Corona Remedies, Wakefit Innovations, and KSH International. Here’s a complete breakdown of upcoming IPOs, listings, allotments, GMP trends, and what investors should watch between December 15–19.



Introduction: A Busy Week Ahead for the Indian IPO Market

The Indian stock market is heading into an action-packed second half of December, with multiple IPOs opening, listing, and finalising allotments across a wide range of sectors. From asset management and pharmaceuticals to healthcare services, consumer durables, and manufacturing, the primary market calendar reflects sustained investor appetite despite selective participation.

What makes this week particularly interesting is the mix of mega issues and mid-sized offerings, combined with strong grey market premiums (GMPs) for some names and muted expectations for others. Heavyweights like ICICI Prudential AMC dominate the fundraising landscape, while eagerly awaited listings such as Corona Remedies and Wakefit Innovations will test investor sentiment on debut.

Let’s take a detailed look at all upcoming IPOs, listings, allotments, and GMP trends scheduled between December 15 and December 19, and what they mean for investors.

Open IPOs: ICICI Prudential AMC Commands Attention

ICICI Prudential AMC IPO – A Mega Issue in Focus

One of the most talked-about public issues of the year, the ICICI Prudential Asset Management Company IPO, is currently open for subscription.

  • IPO Opening Date: December 12, 2025

  • IPO Closing Date: December 16, 2025

  • Issue Size: ₹10,602.65 crore

  • Sector: Asset Management / Financial Services

As one of India’s leading mutual fund houses, ICICI Prudential AMC brings a strong brand, a diversified product portfolio, and a long operating history. Given its scale and profitability, the IPO has drawn strong interest from institutional investors, while retail investors are weighing valuation comfort and long-term growth potential.

This issue is significant not just because of its size, but also because it reflects growing confidence in India’s financialisation and mutual fund penetration story.

Upcoming IPOs Opening Next Week

KSH International IPO – Manufacturing Meets Exports

Among IPOs opening next week, KSH International Limited stands out as a prominent industrial play.

  • IPO Open: December 16

  • IPO Close: December 18

  • Issue Size: ₹710 crore (Book-built)

  • Price Band: ₹365 – ₹384 per share

  • Listing Date: December 23, 2025

  • Exchanges: BSE & NSE

Founded in 1979, KSH International is India’s third-largest manufacturer and the largest exporter of magnet winding wires. The company supplies to OEMs across power, renewable energy, railways, automotive, and industrial segments.

With India’s push toward electrification, renewable energy, and domestic manufacturing, KSH’s positioning aligns well with long-term industrial trends. The allotment for this IPO is expected to be finalised on December 19.

IPOs Set to List: Corona Remedies & Wakefit Innovations

Corona Remedies IPO – Strong GMP Signals Optimism

The Corona Remedies IPO is scheduled to make its stock market debut on December 15, and investor expectations are notably high.

  • IPO Size: ₹655.37 crore

  • Issue Type: Book-built

  • Issue Price: ₹1,062 per share

  • Allotment Date: December 11

  • Listing Date: December 15

  • Exchanges: BSE & NSE

Corona Remedies operates across key therapeutic areas such as women’s healthcare, cardiology, pain management, and urology. Its strong domestic presence and expanding product portfolio have attracted investor interest.

Grey Market Premium (GMP):

  • Current GMP: ₹305

  • Expected Listing Gain: ~28.7%

The strong GMP suggests expectations of a solid listing, particularly among short-term investors seeking listing gains.

Wakefit Innovations IPO – Muted but Stable Expectations

The Wakefit Innovations IPO will also list on December 15, offering a contrast to the pharma enthusiasm seen with Corona Remedies.

  • IPO Size: ₹1,288.89 crore

  • Issue Price: ₹195 per share

  • Subscription Status: 2.52 times overall

  • Listing Date: December 15

Wakefit, a well-known direct-to-consumer (D2C) brand in mattresses and home solutions, witnessed healthy retail and QIB participation but more measured overall demand.

Grey Market Premium (GMP):

  • Current GMP: ₹7

  • Expected Listing Gain: ~3.6%

The modest GMP reflects investor selectivity in consumer-focused listings, where profitability and margin visibility are under closer scrutiny.

IPO Allotments & Listings Scheduled Next Week

Park Medi World IPO – Hospital Chain Expansion Story

The Park Medi World IPO is expected to finalise its allotment on December 15, with listing scheduled for December 17.

  • IPO Size: ₹920 crore

  • Price Band: ₹154 – ₹162 per share

  • Sector: Healthcare Services / Hospitals

Park Mediworld operates a chain of private hospitals, primarily across North India, and benefits from rising demand for quality healthcare infrastructure.

GMP Trend:

  • Current GMP: ₹7

  • Expected Gain: ~4.3%

Nephrocare Health IPO – Niche Healthcare Play

Another healthcare-focused IPO, Nephrocare Health, will also see allotment finalisation on December 15 and listing on December 17, 2025.

  • IPO Size: ₹871.05 crore

  • Price Band: ₹438 – ₹460 per share

  • Sector: Renal Care & Dialysis Services

Nephrocare operates in the specialised field of renal care, a segment with long-term demand visibility due to rising lifestyle-related illnesses.

Grey Market Premium (GMP):

  • Current GMP: ₹33

  • Expected Gain: ~7.2%

The relatively stronger GMP suggests better listing expectations compared to broader hospital chains.

What This Means for Investors

The December 15–19 IPO calendar highlights several important trends:

  1. Institutional Confidence Remains Strong
    Large issues like ICICI Prudential AMC indicate sustained institutional participation in quality businesses.

  2. Healthcare Continues to Dominate
    Pharma, hospitals, and specialised healthcare services remain popular, driven by defensive demand and growth visibility.

  3. Selective Retail Participation
    Retail investors are increasingly selective, especially in consumer-facing and D2C businesses where valuation sensitivity is high.

  4. GMP as a Short-Term Indicator, Not a Guarantee
    While GMP offers insight into market sentiment, actual listing performance can differ based on broader market conditions.

Conclusion: A Defining Week for the Primary Market

The second half of December is shaping up to be a defining phase for India’s primary markets. With blockbuster IPOs, high-profile listings, and multiple allotments lined up, investors have no shortage of opportunities—but also no room for complacency.

Whether you’re a long-term investor evaluating fundamentals or a short-term participant eyeing listing gains, this week demands careful analysis, disciplined allocation, and realistic expectations.

As always, aligning IPO participation with your financial goals and risk tolerance remains key.

Author’s Note

This article is intended for informational and educational purposes only and does not constitute investment advice. IPO investments are subject to market risks, including volatility on listing day. Investors are advised to read offer documents carefully and consult certified financial advisors before making any investment decisions.


Location: Mumbai, Maharashtra, India
Welcome to The Financial and Tech Literacy! I’m Awdhesh Kumar, a finance and tech enthusiast with 20+ years of experience in accounts, taxation, and the stock market. This blog simplifies finance and digital topics for all—students, professionals, retirees, and new investors. Learn about stock market strategies, personal finance, mutual funds, tech tools, digital banking, and government schemes. All content is original, practical, and based on real experience—no paid promotions or clickbait. We refer to trusted sources like SEBI, RBI, NSE, and Economic Times. Stay updated, make informed decisions, and grow financially with us. For contact: awdheshdube65@gmail.com.

Comments

Post a Comment